New facility will provide end-to-end solution to accelerate cell therapy development and manufacturing WALTHAM, Mass. and SAN FRANCISCO — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. […]
Funding will be used to advance the development of AI-based cell analysis and sorting platforms in cell therapy and diagnostics Tokyo, Japan — ThinkCyte, Inc., a company focusing on the development of novel cell therapy, drug discovery and diagnostic platforms, announced today the completion of a $26 million (JPY 2.85 billion) Series B financing, led […]
— Provides automated sample preparation and data analysis workflow for single EV imaging at very high resolution — ONI, a rapidly growing company redefining the boundaries of microscopy with its Nanoimager platform that enables imaging of individual molecules in living cells, today announced the early release of its new, single imaging, extracellular vesicle (EV) comsumable kit, during […]
Funds played a key role in positioning LUMICKS for future success Amsterdam, the Netherlands — LUMICKS, a leading next generation life science tools company renowned for its innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, announces that it has made the decision to return the COVID-related relief funding it received in both the Netherlands […]
IsoPlexis adds Switzerland as the latest country with access to their unique functional single-cell proteomics platform, adding to their existing partnerships across Asia and Europe. BRANFORD, Conn. — IsoPlexis, the leader in single-cell proteomics, today announced an exclusive agreement with Bucher Biotec AG, a Swiss distributor company representing some of the most advanced US, European, and […]
Lonza launches next-generation 4D-Nucleofector® Platform, the leading non-viral cell transfection method for a wide variety of cell types – even those traditionally hard to transfect Modular design offers unmatched flexibility in scale and throughput with proven performance 4D-Nucleofector® Core Unit with user experience upgrade for even more intuitive experimental setup and data management Quote from […]
Lipid-polymer nanocomplexes (LPNCs) developed by Mirus enable superior transfection performance in a range of delivery applications Investment will support GMP launch of TransIT VirusGEN for high-productivity, cell-adaptive transfection in viral vector manufacturing Highly complementary engineering and delivery capabilities extend Gamma’s advanced therapy offering Menlo Park, CA and Madison, WI – Gamma Biosciences, a global life […]
Developed in cooperation with Innovative Sensor Technology IST AG, Sartorius has launched BioPAT® Foam as part of its Biostat STR® Generation 3 system. The BioPAT® Foam is a single-use sensing system used to monitor foam level in single-use bioreactors. Ebnat-Kappel — A good deal of current pharmaceutical production relies on cell cultures with single-use systems […]
Winner will receive Organ-on-Chip products and training to initiate complex research projects BOSTON, Mass. – Emulate, Inc., a leading provider of advanced in vitro models, today launched the Emulate Colon Intestine-Chip Grant Program. The program will help researchers begin using Organs-on-Chips technology to study intestinal diseases. The Emulate Colon Intestine-Chip is a physiologically-relevant model of […]
The partnership brings together one of the world’s premier microscopy vendors and Akoya’s high-parameter CODEX® System for advancing the emerging field of spatial phenotyping and discovery MARLBOROUGH, Mass. — Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced that it has entered into an agreement with ZEISS to co-market Akoya’s CODEX® spatial phenotyping […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
